1. Introduction
In parallel with the development of biocompatible materials, the technological evolution of additive manufacturing (AM) has made possible a beneficial approach between both fields, which has opened new horizons for applications related to biomechanics and biomedical engineering [
1,
2]. Furthermore, this technological advance and transformations have attracted the attention of the health sector to AM, especially in those areas in which a high degree of personalisation of treatments and devices is decisive for its success. This is the case, for example, of orthopaedics and rehabilitation, where AM has been advancing in recent years [
3,
4].
The immediate repair of bone disorders has been an ancestral clinical need, which has required the use of considerable resources in the field of medicine. Although many and various solutions have been successfully implemented, both internal and external treatment of bone defects remains a scientific challenge, as materials with adequate mechanical performance and favourable biological properties are required simultaneously [
5]. However, with the current development of engineering-grade polymeric materials and the possibility of developing custom components by AM, new and versatile applications have been revealed for the biomechanical field in general, and orthopaedic in particular [
6].
In addition, the development of the health sector, which has significantly increased life expectancy, has led to an increase in the elderly population, which is estimated to be 90% with bone problems after 40 years [
7]. For example, from an economic perspective, musculoskeletal disorders totalled around EUR 228 billion in treatments, interventions, and research in 2008 [
7].
AM currently allows the artificial geometrical reproduction of bones, exoskeletons, or anatomically identical parts to be replaced or reinforced. Several studies have approached this perspective, providing interesting analyses about the multiple applications of 3D printing with polymers of different nature for anatomical models or tissue engineering [
8], in the use of metal alloys for orthopaedics and dentistry [
9], in the control of necessary stiffness and porosity to manufacture bone implants with functional success [
10,
11], as well as the management of the entire range of AM technologies, indicating the most suitable application areas [
12,
13]. However, obtaining AM materials not rejected by the body is not a trivial task.
The bone can be considered a material composed of hydroxyapatite and type I collagen [
14], showing inherent anisotropy and heterogeneity, which makes it difficult to establish a generalised value of the modulus of elasticity since it can vary between 2 and 30 GPa, depending on the type of bone, its porosity, and its direction [
15]. Thus, despite the effort to understand the architecture of biological bone [
16], the design of bone inserts, and their use in external immobilisation for disorders requiring intensive rehabilitation, there are still many relevant limitations that slow down the widespread insertion of these new materials in applied medicine.
New expectations have been created as AM technologies are being consolidated. AM generally consists of layer-by-layer deposition of material in a controlled manner until a three-dimensional structure of high geometric complexity is formed. Characteristics such as slenderness, internal casting, changeling, variable thicknesses, irregular shapes, and the reproduction of nature (search for ergonomics, aerodynamics, hydrodynamics, etc.) are challenges that conventional manufacturing methods (subtractive and conformative) have not addressed with the same success [
17,
18]. In addition, the expected customisation in the design of prostheses or orthoses for their complete adaptation does not make this process more costly, which makes it ideal for this sector, in which end products with high added value are desirable [
19]. These benefits have facilitated investment in preclinical testing and clinical applications, as well as new perspectives for bone implants based on AM [
20].
Nowadays, it has been shown that the imitation of the structural characteristics of human biological bone using substitute orthopaedic polymers has advantages for its implantation [
5]. The anatomical complexity, details of the support structure, and variations in the densities, among other peculiarities, are characteristics that can be solved with the reproduction of a model by AM. While reducing the associated cost compared with the conventional manufacturing process, this total customisation makes it possible to obtain a prosthesis or an orthosis equal to the defect to be supplanted or corrected. This advantage undoubtedly contributes to its successful adaptation.
In orthosis design, the use of customised models is much closer to reality, given the lack of risk involved in their implantation. However, in the case of bone insertions with artificial materials, the applicability is not direct. The strategies commonly used for replacing bone defects are allografts and autografts due to the highest osteoconductivity and osteoinductivity [
21]. Autografts are bone transplants of the patient’s bone, from one area of the bone skeleton to another. In contrast, in the allograft, the donor is of the same species but genetically different. However, several associated disadvantages include limited bone supply, donor site morbidity, or possible transmission of bacterial diseases leading to rejection [
22].
Part of these drawbacks could be addressed with artificial AM inserts that, in addition, allow the manufacture of complex microstructures imitating, e.g., the natural porosity of the bone, necessary for cell proliferation that must lead to the regeneration of the affected area. Studies with widely used materials such as PLA [
17,
23] show that scaffolds designed for these applications, with a porosity of around 30–50%, offer successful cell proliferation and osteoconduction results. However, the mechanical performance cannot be equated to those of bone tissue. In other words, the concept of meta-biomaterial [
24], taking advantage of the auxetic characteristic of the proposed configuration, is only addressed to tackle problems of stiffness–expansion in the bone–implant contact or to address the mechanical performance under conditions of quasi-static and cyclic loads [
25]. Nevertheless, in studies on polymers, most authors conclude that thermoplastics could be useful if they are mixed with other materials that help them achieve the required strengths [
18,
21].
The biocompatible PC-ISO polycarbonate is currently a material postulated as a promising candidate for part of these applications. It encompasses a series of outstanding properties for use in the health industry, especially those in direct contact with humans, due to their compliance with ISO 10993 [
26] and USP Class VI certifications (Class Testing standards by the United States Pharmacopeia and National Formulary). This polymeric material in filament form can be used for printing by FFF [
23,
27], one of the most versatile AM technologies [
22]. However, to precisely define its application areas, it is necessary to understand its mechanical performance thoroughly. It has already been shown in previous studies with engineering-grade polymers [
28,
29,
30] that the variability of its properties is highly dependent on printing conditions. It may even be essential to use a solvent to eliminate the support material necessary to print highly complex geometric structures such as those proposed for this type of application, without this implying a deterioration of the mechanical behaviour [
31,
32].
Accordingly, this work aimed to investigate the mechanical performance of PC-ISO 3D-printable synthetic polymer as a potentially competent structural material for use in applied biomechanics. A detailed examination was made of the parametric configuration to complete this objective, defining the combination of parameters that provide optimal mechanical performance beyond the general data reported on manufacturer datasheets [
33]. This information determined the extent to which this material can meet the structural requirements and mechanical stresses expected in such applications and, in turn, clarified the magnitude of the contribution that other materials combined with PC-ISO would have to make to meet user expectations. Therefore, a comprehensive mechanical characterisation of PC-ISO is presented throughout the study, including analysis into the effect of FFF printing parameters on its static, dynamic, and fatigue performance. This allows a complete understanding of its limitations and strengths and provides the scientific community with essential information to determine in which bio-structural applications this biocompatible material would be most appropriate.